Article info
PDFInterstitial lung disease
Original article
PGC1α repression in IPF fibroblasts drives a pathologic metabolic, secretory and fibrogenic state
- Correspondence to Dr Giovanni Ligresti, Physiology & Biomedical Engineering, Mayo Clinic Minnesota, Rochester, MN 55905, USA; ligresti@bu.edu
Citation
PGC1α repression in IPF fibroblasts drives a pathologic metabolic, secretory and fibrogenic state
Publication history
- Received January 9, 2019
- Revised April 16, 2019
- Accepted May 18, 2019
- First published June 10, 2019.
Online issue publication
July 15, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.